{
    "nodes": [
        [
            "integrin",
            "GENE"
        ],
        [
            "EMT",
            "GENE"
        ],
        [
            "alpha-SMA",
            "GENE"
        ],
        [
            "TNF",
            "GENE"
        ],
        [
            "IPF - idiopathic pulmonary fibrosis",
            "DISEASE"
        ],
        [
            "SPTAN1",
            "GENE"
        ],
        [
            "TGFB1",
            "GENE"
        ],
        [
            "IL6",
            "GENE"
        ],
        [
            "PDGFR",
            "GENE"
        ],
        [
            "BLM",
            "GENE"
        ],
        [
            "LOXL2",
            "GENE"
        ],
        [
            "CTGF",
            "GENE"
        ],
        [
            "ACTG2",
            "GENE"
        ]
    ],
    "edges": [
        [
            [
                "IPF - idiopathic pulmonary fibrosis",
                "EMT"
            ],
            21.986539999999998,
            [
                [
                    "Quynh-Chi Nguyen, Hoang-Anh Nguyen, Tuan-Anh Pham, Van Thi-Hong Tran, Thuy-Duong Nguyen, Duc-Vinh Pham (2024). Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization. Journal of ethnopharmacology, 118226. https://doi.org/10.1016/j.jep.2024.118226 PMID: 38670401",
                    "38670401"
                ],
                [
                    "Sarah L Barron, Owen Wyatt, Andy O'Connor, David Mansfield, E Suzanne Cohen, Tomasz M Witkos, Sam Strickson, Róisín M Owens (2024). Modelling bronchial epithelial-fibroblast cross-talk in idiopathic pulmonary fibrosis (IPF) using a human-derived in vitro air liquid interface (ALI) culture. Scientific reports, 240. https://doi.org/10.1038/s41598-023-50618-y PMID: 38168149",
                    "38168149"
                ],
                [
                    "Xiaohua Gu, Zeyu Liu, Shan Shan, Tao Ren, Shaoyang Wang (2024). Airway basal cell‑derived exosomes suppress epithelial‑mesenchymal transition of lung cells by inhibiting the expression of ANO1. Experimental and therapeutic medicine, 219. https://doi.org/10.3892/etm.2024.12507 PMID: 38590572",
                    "38590572"
                ],
                [
                    "Reyhaneh Niayesh-Mehr, Mojtaba Kalantar, Giulio Bontempi, Claudia Montaldo, Saeedeh Ebrahimi, Abdolamir Allameh, Ghader Babaei, Faezeh Seif, Raffaele Strippoli (2024). The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19. Cell communication and signaling : CCS, 542. https://doi.org/10.1186/s12964-024-01925-y PMID: 39538298",
                    "39538298"
                ],
                [
                    "Shraddha Karande, Biswajit Das, Sushree Subhadra Acharya, Anoop Kumar, Harun Patel, Ajay Sharma, Madhu Gupta, Iqrar Ahmad, Vishwambhar Bhandare, Kalicharan Sharma, Chanakya Nath Kundu, Chandragouda Patil (2024). Computational and in vitro screening validates the repositioning potential of Coxibs as anti-fibrotic agents. Journal of biomolecular structure & dynamics, 1-13. https://doi.org/10.1080/07391102.2024.2318655 PMID: 38433403",
                    "38433403"
                ],
                [
                    "Min Liu, Yingying Sheng, Mengyu Li, Tianyu Pan, Wei Jiang, Yafei Zhang, Xin Pan, Cheng Huang, Jun Li, Yuanyuan Wang (2024). METTL3-Dependent YTHDF2 Mediates TSC1 Expression to Regulate Alveolar Epithelial Mesenchymal Transition and Promote Idiopathic Pulmonary Fibrosis. Journal of cellular physiology. https://doi.org/10.1002/jcp.31473 PMID: 39606797",
                    "39606797"
                ],
                [
                    "Zijian Xu, Elizabeth R Davies, Liudi Yao, Yilu Zhou, Juanjuan Li, Aiman Alzetani, Ben G Marshall, David Hancock, Tim Wallis, Julian Downward, Rob M Ewing, Donna E Davies, Mark G Jones, Yihua Wang (2024). LKB1 depletion-mediated epithelial-mesenchymal transition induces fibroblast activation in lung fibrosis. Genes & diseases, 101065. https://doi.org/10.1016/j.gendis.2023.06.034 PMID: 38222900",
                    "38222900"
                ],
                [
                    "Jianying Qi, Yuanyuan Wu, Zhimou Guo, Shenglong Zhu, Jingjing Xiong, Fei Hu, Xinmiao Liang, Xianlong Ye (2024). Fibroblast growth factor 21 alleviates idiopathic pulmonary fibrosis by inhibiting PI3K-AKT-mTOR signaling and stimulating autophagy. International journal of biological macromolecules, 132896. https://doi.org/10.1016/j.ijbiomac.2024.132896 PMID: 38851619",
                    "38851619"
                ],
                [
                    "Qiongyin Zhang, Ning An, Yang Liu, Ying Zhu, Wuliang Pan, Peiling Gu, Jinzhu Zhao, Qiang Pu, Wen Zhu (2024). Alveolar type 2 cells marker gene SFTPC inhibits epithelial-to-mesenchymal transition by upregulating SOX7 and suppressing WNT/β-catenin pathway in non-small cell lung cancer. Frontiers in oncology, 1448379. https://doi.org/10.3389/fonc.2024.1448379 PMID: 39346732",
                    "39346732"
                ],
                [
                    "Chenchun Ding, Zhenzhen Guo, Quan Liao, Renjie Zuo, Junjie He, Ziwei Ye, Weibin Chen (2024). Network Pharmacology and Machine Learning Reveal Salidroside's Mechanisms in Idiopathic Pulmonary Fibrosis Treatment. Journal of inflammation research, 9453-9467. https://doi.org/10.2147/JIR.S493171 PMID: 39600682",
                    "39600682"
                ]
            ]
        ],
        [
            [
                "LOXL2",
                "IPF - idiopathic pulmonary fibrosis"
            ],
            30.568859,
            [
                [
                    "Milena S Espindola, David M Habiel, Ana Lucia Coelho, Tanyalak Parimon, Peter Chen, Amanda Mikels-Vigdal, Cory M Hogaboam (2023). Translational Studies Reveal the Divergent Effects of Simtuzumab Targeting LOXL2 in Idiopathic Pulmonary Fibrosis. Fibrosis (Hong Kong, China). https://doi.org/10.35534/fibrosis.2023.10007 PMID: 38873180",
                    "38873180"
                ],
                [
                    "Ioannis Tomos, Ioannis Roussis, Andreas M Matthaiou, Katerina Dimakou (2023). Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now? Biomedicines. https://doi.org/10.3390/biomedicines11102796 PMID: 37893169",
                    "37893169"
                ],
                [
                    "Hsiao-Yen Ma, Qingling Li, Weng Ruh Wong, Elsa-Noah N'Diaye, Patrick Caplazi, Hannah Bender, Zhiyu Huang, Alexander Arlantico, Surinder Jeet, Aaron Wong, Claire Emson, Hans Brightbill, Lucinda Tam, Robert Newman, Merone Roose-Girma, Wendy Sandoval, Ning Ding (2023). LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung. Science advances, eadf0133. https://doi.org/10.1126/sciadv.adf0133 PMID: 37235663",
                    "37235663"
                ],
                [
                    "Romane Vizier, Anaïs-Rachel Garnier, Alexandre Dias, Mathieu Moreau, Michael Claron, Bertrand Collin, Franck Denat, Pierre-Simon Bellaye, Victor Goncalves (2023). SPECT Imaging of Lysyl Oxidase-like 2 in a Model of Idiopathic Pulmonary Fibrosis. Molecular pharmaceutics, 3613-3622. https://doi.org/10.1021/acs.molpharmaceut.3c00232 PMID: 37307296",
                    "37307296"
                ],
                [
                    "Ying Wei, Wenting Dong, Julia Jackson, Tsung-Che Ho, Claude Jourdan Le Saux, Alexis Brumwell, Xiaopeng Li, Julia Klesney-Tait, Max L Cohen, Paul J Wolters, Harold A Chapman (2021). Blocking LOXL2 and TGFβ1 signalling induces collagen I turnover in precision-cut lung slices derived from patients with idiopathic pulmonary fibrosis. Thorax, 729-732. https://doi.org/10.1136/thoraxjnl-2020-215745 PMID: 33472968",
                    "33472968"
                ],
                [
                    "Ruo-Fei Li, Xin-Yue Chen, Yong Xu, Fan-Chao Feng, Hai-Lang He, Xian-Mei Zhou (2021). Inhibitory effects of alkaline extract from the pericarp of Citrus reticulata Blanco on collagen behavior in bleomycin-induced pulmonary fibrosis. Journal of ethnopharmacology, 113761. https://doi.org/10.1016/j.jep.2020.113761 PMID: 33383114",
                    "33383114"
                ],
                [
                    "Yubin Fan, Rongling He, Lijun Zou, Jie Meng (2020). [Clinical value of biomarkers in diagnosis and treatment of idiopathic pulmonary fibrosis]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 1062-1065. https://doi.org/10.12122/j.issn.1673-4254.2020.07.23 PMID: 32895164",
                    "32895164"
                ],
                [
                    "Lijun Chen, Shifeng Li, Wande Li (2019). LOX/LOXL in pulmonary fibrosis: potential therapeutic targets. Journal of drug targeting, 790-796. https://doi.org/10.1080/1061186X.2018.1550649 PMID: 30457362",
                    "30457362"
                ],
                [
                    "D J Leeming, N Willumsen, J M B Sand, S Holm Nielsen, B Dasgupta, C Brodmerkel, M Curran, C L Bager, M A Karsdal (2019). A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis. Biochemistry and biophysics reports, 38-43. https://doi.org/10.1016/j.bbrep.2018.11.002 PMID: 30555938",
                    "30555938"
                ],
                [
                    "Christopher J Philp, Ivonne Siebeke, Debbie Clements, Suzanne Miller, Anthony Habgood, Alison E John, Vidya Navaratnam, Richard B Hubbard, Gisli Jenkins, Simon R Johnson (2018). Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis. American journal of respiratory cell and molecular biology, 594-603. https://doi.org/10.1165/rcmb.2016-0379OC PMID: 29053339",
                    "29053339"
                ]
            ]
        ],
        [
            [
                "IPF - idiopathic pulmonary fibrosis",
                "ACTG2"
            ],
            20.740751000000003,
            [
                [
                    "Noriko Ouji-Sageshima, Aiko Hiyama, Makiko Kumamoto, Masahiro Kitabatake, Atsushi Hara, Ryutaro Furukawa, Shigeto Hontsu, Takeshi Kawaguchi, Noriyoshi Sawabata, Shigeo Muro, Toshihiro Ito (2024). Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients. Cells. https://doi.org/10.3390/cells13242050 PMID: 39768142",
                    "39768142"
                ],
                [
                    "Eon Kurumiya, Mayuu Iwata, Yoshitoshi Kasuya, Koichiro Tatsumi, Takuya Honda, Toshihiko Murayama, Hiroyuki Nakamura (2024). Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis. European journal of pharmacology, 176366. https://doi.org/10.1016/j.ejphar.2024.176366 PMID: 38296153",
                    "38296153"
                ],
                [
                    "Hong Lv, Xingjia Qian, Zhengzheng Tao, Jun Shu, Dongfang Shi, Jing Yu, Guiqin Fan, Qiuhong Qian, Luhong Shen, Bing Lu (2024). HOXA5-induced lncRNA DNM3OS promotes human embryo lung fibroblast fibrosis via recruiting EZH2 to epigenetically suppress TSC2 expression. Journal of thoracic disease, 1234-1246. https://doi.org/10.21037/jtd-23-1145 PMID: 38505042",
                    "38505042"
                ],
                [
                    "Shraddha Karande, Biswajit Das, Sushree Subhadra Acharya, Anoop Kumar, Harun Patel, Ajay Sharma, Madhu Gupta, Iqrar Ahmad, Vishwambhar Bhandare, Kalicharan Sharma, Chanakya Nath Kundu, Chandragouda Patil (2024). Computational and in vitro screening validates the repositioning potential of Coxibs as anti-fibrotic agents. Journal of biomolecular structure & dynamics, 1-13. https://doi.org/10.1080/07391102.2024.2318655 PMID: 38433403",
                    "38433403"
                ],
                [
                    "Chao Sun, Huaman Liu, Baihong Chi, Jia Han, Yasuhiko Koga, Kamyar Afshar, Xue Liu (2024). Improvement of idiopathic pulmonary fibrosis through a combination of Astragalus radix and Angelica sinensis radix via mammalian target of rapamycin signaling pathway-induced autophagy in rat. Journal of thoracic disease, 1397-1411. https://doi.org/10.21037/jtd-24-28 PMID: 38505077",
                    "38505077"
                ],
                [
                    "Soyoung Hwang, Wongil Lee, Dashnamoorthy Ravi, William Devine, Miyong Yong, R Bruce Diebold, Sang-Ae Seung, Nicholas W Ng, Jaekyoo Lee, Anu Gupta, Jong Sung Koh (2024). Novel Small-Molecule ROCK2 Inhibitor GNS-3595 Attenuates Pulmonary Fibrosis in Preclinical Studies. American journal of respiratory cell and molecular biology, 430-441. https://doi.org/10.1165/rcmb.2023-0401OC PMID: 38861338",
                    "38861338"
                ],
                [
                    "Bingqing Yue, Dian Xiong, Juan Chen, Xiucheng Yang, Jin Zhao, Jingbo Shao, Dong Wei, Fei Gao, Man Huang, Jingyu Chen (2024). SPP1 induces idiopathic pulmonary fibrosis and NSCLC progression via the PI3K/Akt/mTOR pathway. Respiratory research, 362. https://doi.org/10.1186/s12931-024-02989-7 PMID: 39369217",
                    "39369217"
                ],
                [
                    "Emanuela Bocchi, Vanessa Pitozzi, Silvia Pontis, Paola L Caruso, Sofia Beghi, Mariafrancesca Caputi, Marcello Trevisani, Francesca Ruscitti (2024). Investigation of Aberrant Basaloid Cells in a Rat Model of Lung Fibrosis. Frontiers in bioscience (Landmark edition), 305. https://doi.org/10.31083/j.fbl2908305 PMID: 39206922",
                    "39206922"
                ],
                [
                    "Hui Lian, Kai Xu, Airu Chang, Yaxuan Wang, Shuaichen Ma, Lianhui Cheng, Wenyu Zhao, Cong Xia, Lan Wang, Guoying Yu (2024). Loss of PTPN21 disrupted mitochondrial metabolic homeostasis and aggravated experimental pulmonary fibrosis. Respiratory research, 426. https://doi.org/10.1186/s12931-024-03041-4 PMID: 39633451",
                    "39633451"
                ],
                [
                    "Xiaoping Zhang, Runxia Shao (2024). LncRNA SNHG8 upregulates MUC5B to induce idiopathic pulmonary fibrosis progression by targeting miR-4701-5p. Heliyon, e23233. https://doi.org/10.1016/j.heliyon.2023.e23233 PMID: 38163156",
                    "38163156"
                ]
            ]
        ],
        [
            [
                "IPF - idiopathic pulmonary fibrosis",
                "IL6"
            ],
            20.714711,
            [
                [
                    "Xinxin Zhang, Yizi Xie, Yan Cai, Huiting Huang, Huiqiu Liang, Gang Liao, Yong Jiang, Xiaoyun Peng, Shaofeng Zhan, Xiufang Huang (2024). RNA-seq analysis and in vivo experiments identified the protective effect of kaempferol on idiopathic pulmonary fibrosis by regulating the PPARG/TNC signaling pathway to reduce ECM deposition. Food & function, 12193-12209. https://doi.org/10.1039/d4fo01474j PMID: 39587935",
                    "39587935"
                ],
                [
                    "Wesam H Abdulaal, Ulfat M Omar, Mustafa Zeyadi, Dina S El-Agamy, Nabil A Alhakamy, Sabrin R M Ibrahim, Naif A R Almalki, Hani Z Asfour, Mohammed W Al-Rabia, Gamal A Mohamed, Mahmoud Elshal (2024). Pirfenidone ameliorates ANIT-induced cholestatic liver injury via modulation of FXR, NF-кB/TNF-α, and Wnt/GSK-3β/β-catenin signaling pathways. Toxicology and applied pharmacology, 117038. https://doi.org/10.1016/j.taap.2024.117038 PMID: 39019095",
                    "39019095"
                ],
                [
                    "Preeti Yadav, Javier Gómez Ortega, Whitney Tamaki, Charles Chien, Kai-Chun Chang, Nivedita Biswas, Sixuan Pan, Julia Nilsson, Xiaoyang Yin, Aritra Bhattacharyya, Kaveh Boostanpour, Tanay Jujaray, Jasper Wang, Tatsuya Tsukui, Dean Sheppard, Baosheng Li, Mazharul Maishan, Hiroki Taenaka, Michael A Matthay, Rieko Muramatsu, Lenka Maliskova, Arnab Ghosh, Walter L Eckalbar, Ari B Molofsky, Paul J Wolters, Stanley J Tamaki, Trever Bivona, Adam R Abate, Allon Wagner, Kevin M Tharp, Mallar Bhattacharya (2024). Macrophage-fibroblast crosstalk drives Arg1-dependent lung fibrosis via ornithine loading. bioRxiv : the preprint server for biology. https://doi.org/10.1101/2023.09.06.556606 PMID: 39211079",
                    "39211079"
                ],
                [
                    "Sarah L Barron, Owen Wyatt, Andy O'Connor, David Mansfield, E Suzanne Cohen, Tomasz M Witkos, Sam Strickson, Róisín M Owens (2024). Modelling bronchial epithelial-fibroblast cross-talk in idiopathic pulmonary fibrosis (IPF) using a human-derived in vitro air liquid interface (ALI) culture. Scientific reports, 240. https://doi.org/10.1038/s41598-023-50618-y PMID: 38168149",
                    "38168149"
                ],
                [
                    "Jiahao Wang, Jiamiao Shi, Ning Jia, Qinru Sun (2024). Identifying Mechanism of RSV for the Treatment of COVID-19 and Idiopathic Pulmonary Fibrosis via Suppressing Inflammation Response Through IL-17 Signaling Pathway from the Perspectives of in silico Study. Current medicinal chemistry. https://doi.org/10.2174/0109298673308841240930044555 PMID: 39400013",
                    "39400013"
                ],
                [
                    "Zhaoxia Ma, Lihua Qiu, Jianxiu Sun, Zhen Wu, Shu Liang, Yunhui Zhao, Jinmei Yang, Shijun Yue, Min Hu, Yanjiao Li (2024). A novel pulmonary fibrosis NOD/SCID murine model with natural aging. BMC pulmonary medicine, 457. https://doi.org/10.1186/s12890-024-03268-3 PMID: 39285370",
                    "39285370"
                ],
                [
                    "Pierachille Santus, Juan Camilo Signorello, Fiammetta Danzo, Giada Lazzaroni, Marina Saad, Dejan Radovanovic (2024). Anti-Inflammatory and Anti-Oxidant Properties of N-Acetylcysteine: A Fresh Perspective. Journal of clinical medicine. https://doi.org/10.3390/jcm13144127 PMID: 39064168",
                    "39064168"
                ],
                [
                    "Sida Shao, Nan Zhang, Gregory P Specht, Shaochen You, Lirui Song, Qiangwei Fu, David Huang, Hengyao You, Jian Shu, Alain Domissy, Shuangwei Li, Van Nguyen-Tran, Sean B Joseph, Arnab K Chatterjee, Jeffrey Jian Chen, Peter G Schultz, Michael J Bollong (2024). Pharmacological expansion of type 2 alveolar epithelial cells promotes regenerative lower airway repair. Proceedings of the National Academy of Sciences of the United States of America, e2400077121. https://doi.org/10.1073/pnas.2400077121 PMID: 38598345",
                    "38598345"
                ],
                [
                    "Sayak Khawas, Tushar Kanti Dhara, Neelima Sharma (2024). Efficacy of umbelliferone-loaded nanostructured lipid carrier in the management of bleomycin-induced idiopathic pulmonary fibrosis: experimental and network pharmacology insight. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-024-03744-x PMID: 39718612",
                    "39718612"
                ],
                [
                    "Shih-Ching Lee, Chen-Hao Huang, Yen-Jen Oyang, Hsuan-Cheng Huang, Hsueh-Fen Juan (2024). Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease. Journal of translational medicine, 600. https://doi.org/10.1186/s12967-024-05403-4 PMID: 38937794",
                    "38937794"
                ]
            ]
        ],
        [
            [
                "PDGFR",
                "IPF - idiopathic pulmonary fibrosis"
            ],
            11.706417,
            [
                [
                    "BreAnne MacKenzie, Poornima Mahavadi, Yago Amigo Pinho Jannini-Sa, Brecht Creyns, Ana Lucia Coelho, Milena Espindola, Clemens Ruppert, Konrad Hötzenecker, Cory Hogaboam, Andreas Guenther (2024). Pre-clinical proof-of-concept of anti-fibrotic activity of caveolin-1 scaffolding domain peptide LTI-03 in ex vivo precision cut lung slices from patients with Idiopathic Pulmonary Fibrosis. bioRxiv : the preprint server for biology. https://doi.org/10.1101/2024.04.24.589970 PMID: 38712072",
                    "38712072"
                ],
                [
                    "Dhruti Thakkar, Sanskriti Singh, Sarika Wairkar (2024). Advanced Delivery Strategies of Nintedanib for Lung Disorders and Beyond: A Comprehensive Review. AAPS PharmSciTech, 150. https://doi.org/10.1208/s12249-024-02869-9 PMID: 38954161",
                    "38954161"
                ],
                [
                    "Mégane Lebel, Dominic O Cliche, Martine Charbonneau, Damien Adam, Emmanuelle Brochiero, Claire M Dubois, André M Cantin (2022). Invadosome Formation by Lung Fibroblasts in Idiopathic Pulmonary Fibrosis. International journal of molecular sciences. https://doi.org/10.3390/ijms24010499 PMID: 36613948",
                    "36613948"
                ],
                [
                    "Annette D Rieg, Said Suleiman, Carolin Anker, Nina A Bünting, Eva Verjans, Jan Spillner, Sebastian Kalverkamp, Saskia von Stillfried, Till Braunschweig, Stefan Uhlig, Christian Martin (2022). Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca2+-sensitisation. Respiratory research, 189. https://doi.org/10.1186/s12931-022-02101-x PMID: 35841089",
                    "35841089"
                ],
                [
                    "Hideki Amano, Yoshio Matsui, Ko Hatanaka, Kanako Hosono, Yoshiya Ito (2021). VEGFR1-tyrosine kinase signaling in pulmonary fibrosis. Inflammation and regeneration, 16. https://doi.org/10.1186/s41232-021-00166-7 PMID: 34082837",
                    "34082837"
                ],
                [
                    "Xiong Chen, Menglin Li, Manru Li, Dongmei Wang, Jinlan Zhang (2021). Harnessing affinity-based protein profiling to reveal a novel target of nintedanib. Chemical communications (Cambridge, England), 3139-3142. https://doi.org/10.1039/d1cc00354b PMID: 33634807",
                    "33634807"
                ],
                [
                    "Claudia Landi, Laura Bergantini, Paolo Cameli, Miriana d'Alessandro, Alfonso Carleo, Enxhi Shaba, Paola Rottoli, Luca Bini, Elena Bargagli (2020). Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy. Scientific reports, 9378. https://doi.org/10.1038/s41598-020-66296-z PMID: 32523095",
                    "32523095"
                ],
                [
                    "Saeko Takahashi, Saori Murata, Yudai Yoshino, Yosuke Kobayashi, Morio Nakamura (2019). Gastric perforation related to concurrent use of nintedanib and ramucirumab. Respirology case reports, e00383. https://doi.org/10.1002/rcr2.383 PMID: 30455955",
                    "30455955"
                ],
                [
                    "Yi-Chun Wang, Qiong Chen, Jun-Ming Luo, Jing Nie, Qing-He Meng, Wei Shuai, Han Xie, Jia-Mei Xia, Hui Wang (2019). Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR/ROCK1 signal pathway. Experimental & molecular medicine, 1-11. https://doi.org/10.1038/s12276-019-0228-0 PMID: 30902967",
                    "30902967"
                ],
                [
                    "Kazuya Koyama, Hisatsugu Goto, Shun Morizumi, Kozo Kagawa, Haruka Nishimura, Seidai Sato, Hiroshi Kawano, Yuko Toyoda, Hirohisa Ogawa, Sakae Homma, Yasuhiko Nishioka (2019). The Tyrosine Kinase Inhibitor TAS-115 Attenuates Bleomycin-induced Lung Fibrosis in Mice. American journal of respiratory cell and molecular biology, 478-487. https://doi.org/10.1165/rcmb.2018-0098OC PMID: 30540913",
                    "30540913"
                ]
            ]
        ],
        [
            [
                "IPF - idiopathic pulmonary fibrosis",
                "SPTAN1"
            ],
            43.468140000000005,
            [
                [
                    "A Scott McCall, Sergey Gutor, Hari Tanjore, Ankita Burman, Taylor Sherrill, Micah Chapman, Carla L Calvi, David Han, Jane Camarata, Raphael P Hunt, David Nichols, Nicholas E Banovich, William E Lawson, Jason J Gokey, Jonathan A Kropski, Timothy S Blackwell (2025). Hypoxia-inducible factor 2 regulates alveolar regeneration after repetitive injury in three-dimensional cellular and in vivo models. Science translational medicine, eadk8623. https://doi.org/10.1126/scitranslmed.adk8623 PMID: 39772774",
                    "39772774"
                ],
                [
                    "Hye Jin Jang, Yu Min Seong, Jihyeon Jeong, Jin-Young Huh, Jin-Ho Kim, Kyung Hoon Kim, Joo Hun Park, Won-Il Choi (2025). Association between calcium channel blocker use and the risk of interstitial lung disease and idiopathic pulmonary fibrosis: A longitudinal cohort study. Respiratory medicine, 107939. https://doi.org/10.1016/j.rmed.2025.107939 PMID: 39755283",
                    "39755283"
                ],
                [
                    "Min Hyung Ryu, Jeong H Yun, Kangjin Kim, Michele Gentili, Auyon Ghosh, Frank Sciurba, Lucas Barwick, Andrew Limper, Gerard Criner, Kevin K Brown, Robert Wise, Fernando J Martinez, Kevin R Flaherty, Michael H Cho, Peter J Castaldi, Dawn L DeMeo, Edwin K Silverman, Craig P Hersh, Jarrett D Morrow (2024). Computational deconvolution of cell type-specific gene expression in COPD and IPF lungs reveals disease severity associations. BMC genomics, 1192. https://doi.org/10.1186/s12864-024-11031-5 PMID: 39695952",
                    "39695952"
                ],
                [
                    "Joseph K Hall, Jason H T Bates, Ramaswamy Krishnan, Jae Hun Kim, Yuqing Deng, Kenneth R Lutchen, Béla Suki (2024). Elucidating the interaction between stretch and stiffness using an agent-based spring network model of progressive pulmonary fibrosis. Frontiers in network physiology, 1396383. https://doi.org/10.3389/fnetp.2024.1396383 PMID: 38840902",
                    "38840902"
                ],
                [
                    "Wei Chen, Wenhui Zhao, Lijuan Wu, Jun Li, Haiyu Zhao, Yunfang Zhao, Yuelin Song (2024). Integrated post-acquisition data processing strategy for rapid steroid sulfate characterization in Toad gall-bladder. Journal of pharmaceutical and biomedical analysis, 115958. https://doi.org/10.1016/j.jpba.2023.115958 PMID: 38198886",
                    "38198886"
                ],
                [
                    "Chengji Jin, Yahong Chen, Yujie Wang, Jia Li, Jin Liang, Shaomao Zheng, Lipeng Zhang, Qiaoyu Li, Yongchao Wang, Fayu Ling, Yongjie Li, Yu Zheng, Qiuli Nie, Qiong Feng, Jing Wang, Huiling Yang (2024). Single-cell RNA sequencing reveals special basal cells and fibroblasts in idiopathic pulmonary fibrosis. Scientific reports, 15778. https://doi.org/10.1038/s41598-024-66947-5 PMID: 38982264",
                    "38982264"
                ],
                [
                    "Xianglin Du, Zhen Ma, Yanqing Xing, Liting Feng, Yupeng Li, Chuanchuan Dong, Xinkai Ma, Rujie Huo, Xinrui Tian (2024). Identification and validation of potential biomarkers related to oxidative stress in idiopathic pulmonary fibrosis. Immunobiology, 152791. https://doi.org/10.1016/j.imbio.2024.152791 PMID: 39180853",
                    "39180853"
                ],
                [
                    "Xinmei Huang, Wufei Si, Xu Ye, Yichao Zhao, Huimin Gu, Mingrui Zhang, Shufei Wu, Yanchen Shi, Xianhua Gui, Yonglong Xiao, Mengshu Cao (2024). Novel 3D-based deep learning for classification of acute exacerbation of idiopathic pulmonary fibrosis using high-resolution CT. BMJ open respiratory research. https://doi.org/10.1136/bmjresp-2023-002226 PMID: 38460976",
                    "38460976"
                ],
                [
                    "Minggao Zhu, Yuhu Yi, Kui Jiang, Yongzhi Liang, Lijun Li, Feng Zhang, Xinglong Zheng, Haiyan Yin (2024). Single-cell combined with transcriptome sequencing to explore the molecular mechanism of cell communication in idiopathic pulmonary fibrosis. Journal of cellular and molecular medicine, e18499. https://doi.org/10.1111/jcmm.18499 PMID: 38887981",
                    "38887981"
                ],
                [
                    "Bin Liu, Xiang Zhang, Zikai Liu, Haihong Pan, Hongxu Yang, Qing Wu, Yan Lv, Tong Shen (2024). A novel model for predicting prognosis in patients with idiopathic pulmonary fibrosis based on endoplasmic reticulum stress-related genes. Cell biology international, 483-495. https://doi.org/10.1002/cbin.12121 PMID: 38238919",
                    "38238919"
                ]
            ]
        ],
        [
            [
                "IPF - idiopathic pulmonary fibrosis",
                "BLM"
            ],
            29.902168,
            [
                [
                    "Yan Yang, Xinmeng Wang, Jie Zhang (2024). Pirfenidone and nintedanib attenuate pulmonary fibrosis in mice by inhibiting the expression of JAK2. Journal of thoracic disease, 1128-1140. https://doi.org/10.21037/jtd-23-1057 PMID: 38505034",
                    "38505034"
                ],
                [
                    "Sana Bahri, Raed Abdennabi, Asma Chaker, Afef Nahdi, Amine Elgheryeni, Mona Mlika, Saloua Jameleddine (2024). Phœnix dactylifera, L. seed oil alleviates Bleomycin-induced pulmonary fibrosis and oxidative stress in Wistar rats. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 45-54. https://doi.org/10.1080/1354750X.2024.2311178 PMID: 38314578",
                    "38314578"
                ],
                [
                    "Jiaqi Bao, Chang Liu, Huafeng Song, Zheying Mao, Wenxin Qu, Fei Yu, Yifei Shen, Jingjing Jiang, Xiao Chen, Ruonan Wang, Qi Wang, Weizhen Chen, Shufa Zheng, Yu Chen (2024). Cepharanthine attenuates pulmonary fibrosis via modulating macrophage M2 polarization. BMC pulmonary medicine, 444. https://doi.org/10.1186/s12890-024-03250-z PMID: 39261812",
                    "39261812"
                ],
                [
                    "Chao Sun, Huaman Liu, Baihong Chi, Jia Han, Yasuhiko Koga, Kamyar Afshar, Xue Liu (2024). Improvement of idiopathic pulmonary fibrosis through a combination of Astragalus radix and Angelica sinensis radix via mammalian target of rapamycin signaling pathway-induced autophagy in rat. Journal of thoracic disease, 1397-1411. https://doi.org/10.21037/jtd-24-28 PMID: 38505077",
                    "38505077"
                ],
                [
                    "Shilan Peng, Yuanyuan Liang, Haotian Zhu, Yike Wang, Yun Li, Zuoquan Zhao, Yesen Li, Rongqiang Zhuang, Lumei Huang, Xianzhong Zhang, Zhide Guo (2024). A nitroreductase responsive probe for early diagnosis of pulmonary fibrosis disease. Redox biology, 103294. https://doi.org/10.1016/j.redox.2024.103294 PMID: 39096854",
                    "39096854"
                ],
                [
                    "Min Liu, Yingying Sheng, Mengyu Li, Tianyu Pan, Wei Jiang, Yafei Zhang, Xin Pan, Cheng Huang, Jun Li, Yuanyuan Wang (2024). METTL3-Dependent YTHDF2 Mediates TSC1 Expression to Regulate Alveolar Epithelial Mesenchymal Transition and Promote Idiopathic Pulmonary Fibrosis. Journal of cellular physiology. https://doi.org/10.1002/jcp.31473 PMID: 39606797",
                    "39606797"
                ],
                [
                    "Wuhao Yang, Hui Yuan, Hao Sun, Ting Hu, Yaping Xu, Yan Qiu, Yuhang Li (2024). Co-Mn Complex Oxide Nanoparticles as Potential Reactive Oxygen Species Scavenging Agents for Pulmonary Fibrosis Treatment. Molecules (Basel, Switzerland). https://doi.org/10.3390/molecules29215106 PMID: 39519747",
                    "39519747"
                ],
                [
                    "Sana Bahri, Souhir Bouazizi, Afef Nahdi, Mona Mlika, Mokhtar Hamdi, Saloua Jameleddine (2024). Insights on the Tunisian Prickly Pear Molasses as a Potential Antifibrotic and Antioxidant Candidate against Lung Fibrosis. Chemistry & biodiversity, e202401030. https://doi.org/10.1002/cbdv.202401030 PMID: 39073317",
                    "39073317"
                ],
                [
                    "Min Hu, Xiao-Hui Guan, Ling-Fang Wang, Hao-Min Xu, Shu-Fen Ke, Qing-Yun Yuan, Hui-Lan Tan, Jie Wu, Guan-Hui Yu, Qi-Ming Huang, Yu Liu, Long Hu, Ke-Yu Deng, Hong-Bo Xin (2024). Endothelial CD38-induced endothelial-to-mesenchymal transition is a pivotal driver in pulmonary fibrosis. Cellular and molecular life sciences : CMLS, 30. https://doi.org/10.1007/s00018-024-05548-x PMID: 39725783",
                    "39725783"
                ],
                [
                    "Xiaoping Zhang, Runxia Shao (2024). LncRNA SNHG8 upregulates MUC5B to induce idiopathic pulmonary fibrosis progression by targeting miR-4701-5p. Heliyon, e23233. https://doi.org/10.1016/j.heliyon.2023.e23233 PMID: 38163156",
                    "38163156"
                ]
            ]
        ],
        [
            [
                "IPF - idiopathic pulmonary fibrosis",
                "TNF"
            ],
            29.352017,
            [
                [
                    "Wesam H Abdulaal, Ulfat M Omar, Mustafa Zeyadi, Dina S El-Agamy, Nabil A Alhakamy, Sabrin R M Ibrahim, Naif A R Almalki, Hani Z Asfour, Mohammed W Al-Rabia, Gamal A Mohamed, Mahmoud Elshal (2024). Pirfenidone ameliorates ANIT-induced cholestatic liver injury via modulation of FXR, NF-кB/TNF-α, and Wnt/GSK-3β/β-catenin signaling pathways. Toxicology and applied pharmacology, 117038. https://doi.org/10.1016/j.taap.2024.117038 PMID: 39019095",
                    "39019095"
                ],
                [
                    "Sarah L Barron, Owen Wyatt, Andy O'Connor, David Mansfield, E Suzanne Cohen, Tomasz M Witkos, Sam Strickson, Róisín M Owens (2024). Modelling bronchial epithelial-fibroblast cross-talk in idiopathic pulmonary fibrosis (IPF) using a human-derived in vitro air liquid interface (ALI) culture. Scientific reports, 240. https://doi.org/10.1038/s41598-023-50618-y PMID: 38168149",
                    "38168149"
                ],
                [
                    "Zhaoxia Ma, Lihua Qiu, Jianxiu Sun, Zhen Wu, Shu Liang, Yunhui Zhao, Jinmei Yang, Shijun Yue, Min Hu, Yanjiao Li (2024). A novel pulmonary fibrosis NOD/SCID murine model with natural aging. BMC pulmonary medicine, 457. https://doi.org/10.1186/s12890-024-03268-3 PMID: 39285370",
                    "39285370"
                ],
                [
                    "Yulei Liang, Yanan Yan, Na Liu, Jiepeng Wang, Chaoyi Fang (2024). Shengxian decoction improves lung function in rats with bleomycin-induced idiopathic pulmonary fibrosis through the inhibition of PANoptosis. Journal of ethnopharmacology, 118153. https://doi.org/10.1016/j.jep.2024.118153 PMID: 38604513",
                    "38604513"
                ],
                [
                    "Zeqi Wu, Ruijia Shi, Shihao Yan, Shaobo Zhang, Bin Lu, Zhenlin Huang, Lili Ji (2024). Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis. Phytomedicine : international journal of phytotherapy and phytopharmacology, 155368. https://doi.org/10.1016/j.phymed.2024.155368 PMID: 38498951",
                    "38498951"
                ],
                [
                    "Shuyu Ge, Zhenghong Guo, Ting Xiao, Pingping Sun, Bo Yang, Yin Ying (2024). Qingfei Tongluo Mixture Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis through mTOR-Dependent Autophagy in Rats. Mediators of inflammation, 5573353. https://doi.org/10.1155/2024/5573353 PMID: 38361765",
                    "38361765"
                ],
                [
                    "Canchao Jia, Minjuan Yang, Guanlin Xiao, Zhihao Zeng, Lingjie Li, Yangxue Li, Jieyi Jiang, Aili Xu, Jinyan Qiu, Ruiyin Tang, Dongmei Li, Dezheng Jia, Canhui Xie, Guangying Wu, Dake Cai, Xiaoli Bi (2024). ESL attenuates BLM-induced IPF in mice: Dual mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a pathways. Phytomedicine : international journal of phytotherapy and phytopharmacology, 155545. https://doi.org/10.1016/j.phymed.2024.155545 PMID: 38972238",
                    "38972238"
                ],
                [
                    "Xiang Lu, Chaoran Zhu, Yiwen Gao, Zhenqiang Yu, Qingqing Yan, Yang Liu, Mingjin Luo, Xiufang Shi (2023). Design, synthesis, and evaluation of pirfenidone-NSAIDs conjugates for the treatment of idiopathic pulmonary fibrosis. Bioorganic chemistry, 107018. https://doi.org/10.1016/j.bioorg.2023.107018 PMID: 38071874",
                    "38071874"
                ],
                [
                    "Michail Spathakis, Gesthimani Tarapatzi, Eirini Filidou, Leonidas Kandilogiannakis, Evangelos Karatzas, Paschalis Steiropoulos, Dimitrios Mikroulis, George M Spyrou, Vangelis G Manolopoulos, George Kolios, Konstantinos Arvanitidis (2023). Niclosamide Attenuates Inflammation-Associated Profibrotic Responses in Human Subepithelial Lung Myofibroblasts. Biomedicines. https://doi.org/10.3390/biomedicines11072032 PMID: 37509671",
                    "37509671"
                ],
                [
                    "Sun Jie, Harish Narasimhan, In Su Cheon, Wei Qian, Shengen Hu, Tanyalak Parimon, Chaofan Li, Nicholas Goplen, Yue Wu, Xiaoqin Wei, Young Min Son, Elizabeth Fink, Gislane Santos, Jinyi Tang, Changfu Yao, Lyndsey Muehling, Glenda Canderan, Alexandra Kadl, Abigail Cannon, Samuel Young, Riley Hannan, Grace Bingham, Mohammad Arish, Arka Sen Chaudhari, Jeffrey Sturek, Patcharin Pramoonjago, Yun Shim, Judith Woodfolk, Chongzhi Zang, Peter Chen (2023). Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19. Research square. https://doi.org/10.21203/rs.3.rs-3587418/v1 PMID: 38077031",
                    "38077031"
                ]
            ]
        ],
        [
            [
                "CTGF",
                "IPF - idiopathic pulmonary fibrosis"
            ],
            13.986978,
            [
                [
                    "Xinglong Zhu, Shengqiang Mao, Ying Yang, Xinmei Liu, Qin Liu, Ning Zhang, Yongfeng Yang, Yanan Li, Mengyu Gao, Ji Bao, Weimin Li, Yi Li (2025). Biomimetic Topological Micropattern Arrays Regulate the Heterogeneity of Cellular Fates in Lung Fibroblasts between Fibrosis and Invasion. ACS nano. https://doi.org/10.1021/acsnano.4c11113 PMID: 39742460",
                    "39742460"
                ],
                [
                    "Rana Mostafa Adel, Hamed Helal, Mona Ahmed Fouad, Sahar Sobhy Abd-Elhalem (2024). Regulation of miRNA-155-5p ameliorates NETosis in pulmonary fibrosis rat model via inhibiting its target cytokines IL-1β, TNF-α and TGF-β1. International immunopharmacology, 111456. https://doi.org/10.1016/j.intimp.2023.111456 PMID: 38159555",
                    "38159555"
                ],
                [
                    "Anil H Kadam, Jan E Schnitzer (2024). Insights into Disease Progression of Translational Preclinical Rat Model of Interstitial Pulmonary Fibrosis through Endpoint Analysis. Cells. https://doi.org/10.3390/cells13060515 PMID: 38534359",
                    "38534359"
                ],
                [
                    "Cheng-Wei Huang, Shih-Yi Lee, Chen-Xuan Du, Shao-Tung Wu, Yueh-Hsiung Kuo, Hui-Chun Ku (2024). Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 116298. https://doi.org/10.1016/j.biopha.2024.116298 PMID: 38394850",
                    "38394850"
                ],
                [
                    "Takuma Isshiki, Safaa Naiel, Megan Vierhout, Kohei Otsubo, Pareesa Ali, Kazuya Tsubouchi, Parichehr Yazdanshenas, Vaishnavi Kumaran, Anna Dvorkin-Gheva, Martin R J Kolb, Kjetil Ask (2024). Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases. Pharmacology & therapeutics, 108578. https://doi.org/10.1016/j.pharmthera.2023.108578 PMID: 38103794",
                    "38103794"
                ],
                [
                    "Hassan Hayek, Ohoud Rehbini, Beata Kosmider, Thomas Brandt, Wissam Chatila, Nathaniel Marchetti, Gerard J Criner, Sudhir Bolla, Raj Kishore, Russell P Bowler, Karim Bahmed (2024). The Regulation of Fatty Acid Synthase by Exosomal miR-143-5p and miR-342-5p in Idiopathic Pulmonary Fibrosis. American journal of respiratory cell and molecular biology, 259-282. https://doi.org/10.1165/rcmb.2023-0232OC PMID: 38117249",
                    "38117249"
                ],
                [
                    "Suphachai Tharavecharak, Hajime Fujimoto, Taro Yasuma, Corina N D'Alessandro-Gabazza, Masaaki Toda, Atsushi Tomaru, Haruko Saiki, Mei Uemura, Yurie Kogue, Toshiyuki Ito, Kazuki Furuhashi, Tomohito Okano, Atsuro Takeshita, Kota Nishihama, Ryoichi Ono, Osamu Hataji, Tetsuya Nosaka, Tetsu Kobayashi, Esteban C Gabazza (2024). Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant. Cells. https://doi.org/10.3390/cells13181523 PMID: 39329706",
                    "39329706"
                ],
                [
                    "Jun Chang, Shaoqing Zou, Yiwen Xiao, Du Zhu (2023). Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach. BMC complementary medicine and therapies, 352. https://doi.org/10.1186/s12906-023-04171-w PMID: 37798725",
                    "37798725"
                ],
                [
                    "Yang Miao, Yue Yang, Xiaohe Li, Lingxin Meng, Jiahe Mao, Jianwei Zhang, Jingjing Gao, Cheng Yang, Xiaoting Gu, Honggang Zhou, Yanping Zhang (2023). Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice. Heliyon, e20914. https://doi.org/10.1016/j.heliyon.2023.e20914 PMID: 38027732",
                    "38027732"
                ],
                [
                    "Takuma Isshiki, Megan Vierhout, Safaa Naiel, Pareesa Ali, Parichehr Yazdanshenas, Vaishnavi Kumaran, Zi Yang, Anna Dvorkin-Gheva, Anthony F Rullo, Martin R J Kolb, Kjetil Ask (2023). Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease. Biochemical pharmacology, 115501. https://doi.org/10.1016/j.bcp.2023.115501 PMID: 36921632",
                    "36921632"
                ]
            ]
        ],
        [
            [
                "integrin",
                "IPF - idiopathic pulmonary fibrosis"
            ],
            6.768794,
            [
                [
                    "Panayiotis A Procopiou, John Barrett, Matthew H J Crawford, Richard J D Hatley, Ashley P Hancock, John M Pritchard, James E Rowedder, Royston C B Copley, Robert J Slack, Steven L Sollis, Lee R Thorp, Rhys A Lippa, Simon J F Macdonald, Tim N Barrett (2024). Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin Inhibitors. Journal of medicinal chemistry, 17497-17519. https://doi.org/10.1021/acs.jmedchem.4c01430 PMID: 39269712",
                    "39269712"
                ],
                [
                    "Bryce A Harrison, James E Dowling, Matthew G Bursavich, Dawn M Troast, Katherine M Chong, Kristopher N Hahn, Cheng Zhong, Kristen M Mulvihill, Hanh Nguyen, Meghan F Monroy, Qi Qiao, Brian Sosa, Siavash Mostafavi, Inese Smukste, Dooyoung Lee, Laura Cappellucci, Elizabeth H Konopka, Patrycja Nowakowski, Lukasz Stawski, Mayra Senices, Minh Hai Nguyen, Parmita S Kapoor, Lia Luus, Andrew Sullivan, Andrea Bortolato, Mats Svensson, Eugene R Hickey, Kyle D Konze, Tyler Day, Byungchan Kim, Ana Negri, Aleksey I Gerasyuto, Terence I Moy, Min Lu, Adrian S Ray, Liangsu Wang, Dan Cui, Fu-Yang Lin, Blaise Lippa, Bruce N Rogers (2024). The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin αvβ6 Inhibitor for Fibrosis. Journal of medicinal chemistry, 18656-18681. https://doi.org/10.1021/acs.jmedchem.4c01851 PMID: 39446989",
                    "39446989"
                ],
                [
                    "Kangchen Li, Han Liu, Mingyan Li, Meihao Sun, Xiling Peng, Yuanyuan Wu, Yange Tian, Xinguang Liu, Jiansheng Li (2024). Mechanistic insights into the treatment of pulmonary fibrosis with bioactive components from traditional chinese medicine via matrix stiffness-mediated EMT. Phytomedicine : international journal of phytotherapy and phytopharmacology, 156266. https://doi.org/10.1016/j.phymed.2024.156266 PMID: 39580995",
                    "39580995"
                ],
                [
                    "Gabriel Augusto Oliveira Lopes, Braulio Henrique Freire Lima, Camila Simões Freitas, Andiara Cardoso Peixoto, Frederico Marianetti Soriani, Geovanni Dantas Cassali, Bernhard Ryffel, Mauro Martins Teixeira, Fabiana Simão Machado, Remo Castro Russo (2024). Opposite effects of systemic and local conditional CD11c+ myeloid cell depletion during bleomycin-induced inflammation and fibrosis in mice. Immunity, inflammation and disease, e70042. https://doi.org/10.1002/iid3.70042 PMID: 39582275",
                    "39582275"
                ],
                [
                    "Sarah MacIsaac, Dujrath Somboonviboon, Ciaran Scallan, Martin Kolb (2024). Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials. Expert opinion on emerging drugs, 177-186. https://doi.org/10.1080/14728214.2024.2340723 PMID: 38588523",
                    "38588523"
                ],
                [
                    "Shaojie Huang, Yingying Lin, Qiwen Deng, Yuanjia Zhang, Senyi Peng, Yuan Qiu, Wenqi Huang, Zhongxing Wang, Xiaofan Lai (2024). Suppression of OGN in lung myofibroblasts attenuates pulmonary fibrosis by inhibiting integrin αv-mediated TGF-β/Smad pathway activation. Matrix biology : journal of the International Society for Matrix Biology, 87-97. https://doi.org/10.1016/j.matbio.2024.07.001 PMID: 39019241",
                    "39019241"
                ],
                [
                    "Yingsong Mu, Jing Liu, Qimei Wu, Bo Wang, TingTing Hu, Yiman Li, Xiaoyong Yan, Liang Ma, Zhouke Tan (2024). A dual αvβ1/αvβ6 integrin inhibitor Bexotegrast (PLN-74809) ameliorates organ injury and fibrogenesis in fibrotic kidney disease. European journal of pharmacology, 176983. https://doi.org/10.1016/j.ejphar.2024.176983 PMID: 39243926",
                    "39243926"
                ],
                [
                    "Joshua J Mooney, Susan Jacobs, Éric A Lefebvre, Gregory P Cosgrove, Annie Clark, Scott M Turner, Martin Decaris, Chris N Barnes, Marzena Jurek, Brittney Williams, Heying Duan, Richard Kimura, Gaia Rizzo, Graham Searle, Mirwais Wardak, H Henry Guo (2024). Bexotegrast Shows Dose-dependent Integrin αvβ6 Receptor Occupancy in Lungs of Participants with Idiopathic Pulmonary Fibrosis: A Phase 2, Open-Label Clinical Trial. Annals of the American Thoracic Society. https://doi.org/10.1513/AnnalsATS.202409-969OC PMID: 39499805",
                    "39499805"
                ],
                [
                    "Jessica F Calver, Nimesh R Parmar, Gemma Harris, Ryan M Lithgo, Panayiota Stylianou, Fredrik R Zetterberg, Bibek Gooptu, Alison C Mackinnon, Stephen B Carr, Lee A Borthwick, David J Scott, Iain D Stewart, Robert J Slack, R Gisli Jenkins, Alison E John (2024). Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosis. The Journal of biological chemistry, 107300. https://doi.org/10.1016/j.jbc.2024.107300 PMID: 38641066",
                    "38641066"
                ],
                [
                    "Serena Bellani, Philip L Molyneaux, Toby M Maher, Paolo Spagnolo (2024). Potential of αvβ6 and αvβ1 integrin inhibition for treatment of idiopathic pulmonary fibrosis. Expert opinion on therapeutic targets, 575-585. https://doi.org/10.1080/14728222.2024.2375375 PMID: 38949181",
                    "38949181"
                ]
            ]
        ],
        [
            [
                "IPF - idiopathic pulmonary fibrosis",
                "alpha-SMA"
            ],
            20.091663999999998,
            [
                [
                    "Yongjia Wei, Wenting Ni, Lizhi Zhao, Yanhong Gao, Bing Zhou, Qun Feng, Yun Ma, Limin Wang (2025). Phillygenin Inhibits PI3K-Akt-mTOR Signalling Pathway to Prevent bleomycin-Induced Idiopathic Pulmonary Fibrosis in Mice. Clinical and experimental pharmacology & physiology, e70017. https://doi.org/10.1111/1440-1681.70017 PMID: 39746665",
                    "39746665"
                ],
                [
                    "Xinxin Zhang, Yizi Xie, Yan Cai, Huiting Huang, Huiqiu Liang, Gang Liao, Yong Jiang, Xiaoyun Peng, Shaofeng Zhan, Xiufang Huang (2024). RNA-seq analysis and in vivo experiments identified the protective effect of kaempferol on idiopathic pulmonary fibrosis by regulating the PPARG/TNC signaling pathway to reduce ECM deposition. Food & function, 12193-12209. https://doi.org/10.1039/d4fo01474j PMID: 39587935",
                    "39587935"
                ],
                [
                    "Noriko Ouji-Sageshima, Aiko Hiyama, Makiko Kumamoto, Masahiro Kitabatake, Atsushi Hara, Ryutaro Furukawa, Shigeto Hontsu, Takeshi Kawaguchi, Noriyoshi Sawabata, Shigeo Muro, Toshihiro Ito (2024). Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients. Cells. https://doi.org/10.3390/cells13242050 PMID: 39768142",
                    "39768142"
                ],
                [
                    "Eon Kurumiya, Mayuu Iwata, Yoshitoshi Kasuya, Koichiro Tatsumi, Takuya Honda, Toshihiko Murayama, Hiroyuki Nakamura (2024). Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis. European journal of pharmacology, 176366. https://doi.org/10.1016/j.ejphar.2024.176366 PMID: 38296153",
                    "38296153"
                ],
                [
                    "Gabriel Augusto Oliveira Lopes, Braulio Henrique Freire Lima, Camila Simões Freitas, Andiara Cardoso Peixoto, Frederico Marianetti Soriani, Geovanni Dantas Cassali, Bernhard Ryffel, Mauro Martins Teixeira, Fabiana Simão Machado, Remo Castro Russo (2024). Opposite effects of systemic and local conditional CD11c+ myeloid cell depletion during bleomycin-induced inflammation and fibrosis in mice. Immunity, inflammation and disease, e70042. https://doi.org/10.1002/iid3.70042 PMID: 39582275",
                    "39582275"
                ],
                [
                    "Hong Lv, Xingjia Qian, Zhengzheng Tao, Jun Shu, Dongfang Shi, Jing Yu, Guiqin Fan, Qiuhong Qian, Luhong Shen, Bing Lu (2024). HOXA5-induced lncRNA DNM3OS promotes human embryo lung fibroblast fibrosis via recruiting EZH2 to epigenetically suppress TSC2 expression. Journal of thoracic disease, 1234-1246. https://doi.org/10.21037/jtd-23-1145 PMID: 38505042",
                    "38505042"
                ],
                [
                    "Shufei Wu, Mengying Liu, Mingrui Zhang, Xu Ye, Huimin Gu, Cheng Jiang, Huihui Zhu, Xiaoling Ye, Qi Li, Xinmei Huang, Mengshu Cao (2024). The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis. Frontiers in immunology, 1275064. https://doi.org/10.3389/fimmu.2024.1275064 PMID: 38370408",
                    "38370408"
                ],
                [
                    "Jiaqi Bao, Chang Liu, Huafeng Song, Zheying Mao, Wenxin Qu, Fei Yu, Yifei Shen, Jingjing Jiang, Xiao Chen, Ruonan Wang, Qi Wang, Weizhen Chen, Shufa Zheng, Yu Chen (2024). Cepharanthine attenuates pulmonary fibrosis via modulating macrophage M2 polarization. BMC pulmonary medicine, 444. https://doi.org/10.1186/s12890-024-03250-z PMID: 39261812",
                    "39261812"
                ],
                [
                    "Zhaoxia Ma, Lihua Qiu, Jianxiu Sun, Zhen Wu, Shu Liang, Yunhui Zhao, Jinmei Yang, Shijun Yue, Min Hu, Yanjiao Li (2024). A novel pulmonary fibrosis NOD/SCID murine model with natural aging. BMC pulmonary medicine, 457. https://doi.org/10.1186/s12890-024-03268-3 PMID: 39285370",
                    "39285370"
                ],
                [
                    "Chao Sun, Huaman Liu, Baihong Chi, Jia Han, Yasuhiko Koga, Kamyar Afshar, Xue Liu (2024). Improvement of idiopathic pulmonary fibrosis through a combination of Astragalus radix and Angelica sinensis radix via mammalian target of rapamycin signaling pathway-induced autophagy in rat. Journal of thoracic disease, 1397-1411. https://doi.org/10.21037/jtd-24-28 PMID: 38505077",
                    "38505077"
                ]
            ]
        ],
        [
            [
                "IPF - idiopathic pulmonary fibrosis",
                "TGFB1"
            ],
            93.37208,
            [
                [
                    "Yan Yang, Xinmeng Wang, Jie Zhang (2024). Pirfenidone and nintedanib attenuate pulmonary fibrosis in mice by inhibiting the expression of JAK2. Journal of thoracic disease, 1128-1140. https://doi.org/10.21037/jtd-23-1057 PMID: 38505034",
                    "38505034"
                ],
                [
                    "Seung Sook Paik, Jeong Mi Lee, Il-Gyu Ko, Sae Rom Kim, Sung Wook Kang, Jin An, Jin Ah Kim, Dongyon Kim, Lakkyong Hwang, Jun-Jang Jin, Sang-Hoon Kim, Jun-Youl Cha, Cheon Woong Choi (2024). Pirfenidone Alleviates Inflammation and Fibrosis of Acute Respiratory Distress Syndrome by Modulating the Transforming Growth Factor-β/Smad Signaling Pathway. International journal of molecular sciences. https://doi.org/10.3390/ijms25158014 PMID: 39125585",
                    "39125585"
                ],
                [
                    "Eon Kurumiya, Mayuu Iwata, Yoshitoshi Kasuya, Koichiro Tatsumi, Takuya Honda, Toshihiko Murayama, Hiroyuki Nakamura (2024). Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis. European journal of pharmacology, 176366. https://doi.org/10.1016/j.ejphar.2024.176366 PMID: 38296153",
                    "38296153"
                ],
                [
                    "Joseph K Hall, Jason H T Bates, Ramaswamy Krishnan, Jae Hun Kim, Yuqing Deng, Kenneth R Lutchen, Béla Suki (2024). Elucidating the interaction between stretch and stiffness using an agent-based spring network model of progressive pulmonary fibrosis. Frontiers in network physiology, 1396383. https://doi.org/10.3389/fnetp.2024.1396383 PMID: 38840902",
                    "38840902"
                ],
                [
                    "Hong Lv, Xingjia Qian, Zhengzheng Tao, Jun Shu, Dongfang Shi, Jing Yu, Guiqin Fan, Qiuhong Qian, Luhong Shen, Bing Lu (2024). HOXA5-induced lncRNA DNM3OS promotes human embryo lung fibroblast fibrosis via recruiting EZH2 to epigenetically suppress TSC2 expression. Journal of thoracic disease, 1234-1246. https://doi.org/10.21037/jtd-23-1145 PMID: 38505042",
                    "38505042"
                ],
                [
                    "Zhaoxia Ma, Lihua Qiu, Jianxiu Sun, Zhen Wu, Shu Liang, Yunhui Zhao, Jinmei Yang, Shijun Yue, Min Hu, Yanjiao Li (2024). A novel pulmonary fibrosis NOD/SCID murine model with natural aging. BMC pulmonary medicine, 457. https://doi.org/10.1186/s12890-024-03268-3 PMID: 39285370",
                    "39285370"
                ],
                [
                    "Shraddha Karande, Biswajit Das, Sushree Subhadra Acharya, Anoop Kumar, Harun Patel, Ajay Sharma, Madhu Gupta, Iqrar Ahmad, Vishwambhar Bhandare, Kalicharan Sharma, Chanakya Nath Kundu, Chandragouda Patil (2024). Computational and in vitro screening validates the repositioning potential of Coxibs as anti-fibrotic agents. Journal of biomolecular structure & dynamics, 1-13. https://doi.org/10.1080/07391102.2024.2318655 PMID: 38433403",
                    "38433403"
                ],
                [
                    "Fathimath Muneesa Moideen, Mohamudha Parveen Rahamathulla, Rakshitha Charavu, Fayez Alghofaili, Mohemmed Sha, Yashodhar P Bhandary (2024). PAI-1 influences and curcumin destabilizes MMP-2, MMP-9 and basement membrane proteins during lung injury and fibrosis. International immunopharmacology, 113587. https://doi.org/10.1016/j.intimp.2024.113587 PMID: 39549545",
                    "39549545"
                ],
                [
                    "Chao Sun, Huaman Liu, Baihong Chi, Jia Han, Yasuhiko Koga, Kamyar Afshar, Xue Liu (2024). Improvement of idiopathic pulmonary fibrosis through a combination of Astragalus radix and Angelica sinensis radix via mammalian target of rapamycin signaling pathway-induced autophagy in rat. Journal of thoracic disease, 1397-1411. https://doi.org/10.21037/jtd-24-28 PMID: 38505077",
                    "38505077"
                ],
                [
                    "Archana Vijay Gaikwad, Mathew Suji Eapen, Surajit Dey, Prem Bhattarai, Affan Mahmood Shahzad, Collin Chia, Jade Jaffar, Glen Westall, Darren Sutherland, Gurpreet Kaur Singhera, Tillie-Louise Hackett, Wenying Lu, Sukhwinder Singh Sohal (2024). TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT). Journal of clinical medicine. https://doi.org/10.3390/jcm13041160 PMID: 38398472",
                    "38398472"
                ]
            ]
        ]
    ]
}